GoodRx stock price target raised to $6.00 from $4.50 at UBS Mar. 1, 2023 at 9:31 a.m. ETby Tomi Kilgore GoodRx stock surges 15% after earnings beat Feb. 28, 2023 at 5:42 p.m. ETby Wallace Witkowski FTC fines GoodRx for unauthorized sharing of users’ health data ...
Why GoodRx Stock Soared Today Motley Fool - Thu Feb 29, 2024 The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance. KR : 61.81 (+1.26%) GDRX : 4.89 (-1.21%) GoodRx (GDRX) Q4 2023 Earnings Call Transcript Motley Fool - Thu Feb...
Stock Information Governance Resources Investor Relations About GoodRxOur mission is to help Americans get the healthcare they need at a price they can afford. We are building the leading, consumer-focused digital healthcare platform in the United States. ...
GDRX Price Chart Open Advanced Chart GoodRx Holdings, Inc. stock is down -3.53% since 30 days ago. The next earnings date is May 8, 2025. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of...
But absent that, I think given especially where, given our stock price is at, I think we'll continue to return cash, excess cash back to shareholders in the form of a repo. I think we have $290 million of authorized spend at the board level. So I think we'll probably lean into th...
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. GoodRx shares have added about 5.2% since the beginning of the year versus the S&P 500's gain of...
Options information is delayed a minimum of 15 minutes, and is updated at least once every 15-minutes through-out the day. The screener displaysprobability calculations based on the delayed stock price at the time the strategy is updated.The new day's options data will start populating the scr...
The emc database contains medication characteristics like dose, use, and side effects, package leaflets, audio and video content, safety alert, and additional details like change of ownership, package information, or stock issues. Healthcare tech providers and their drug data APIs Besides official ...
Credit: Adobe Stock/ILOVEART Boehringer Ingelheim and GoodRx have partnered to offer both high-concentration and low-concentration citrate-free formulations ofbiosimilaradalimumab-adbm (Cyltezo) at a 92% discount from the reference drug (adalimumab, Humira) list price.1 ...
companies for the company’s products; the impact of product liability lawsuits; the influence of extensive and costly government regulation; the impact of leadership transitions; the volatility of the trading price of the company’s common stock ...